Yahoo Web Search

Search results

    • Q1 2024 Nektar Therapeutics Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 hours ago

      Notably, the study...after treatment ended, opening up the potential for REZPEG to have an immunomodulatory effect. This past quarter, we initiated our second Phase 2b study ...